A 6 month study to compare the efficacy and safety of 9 ug formoterol b i d in patients with COPD. Furthermore to compare formoterol 4,5 ug as needed with terbutaline 0,5 ug as needed.
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
No locations available